<DOC>
	<DOCNO>NCT02434562</DOCNO>
	<brief_summary>This prospective biobank set collect serum patient disorder associate change androgen , estrogens sex hormone-binding globulin ( SHBG ) , and/or treatment .</brief_summary>
	<brief_title>Development Validation Vitro Cell-based Bioassays Nuclear Receptor Activation</brief_title>
	<detailed_description>In vitro cell-based bioassay may technique measure serum androgen estrogen bioactivity . In study investigator collect serum ( possible , urine ) sample different cohort patient , and/or treatment . The aim measure androgens , estrogens SHBG well vitro bioactivity newly develop cell-based bioassay , compare different technique well clinical endpoint available patient 's Electronic Health Record .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<criteria>Known expect medical condition affect androgen , estrogens SHBG Inability provide write informed consent Known suspect bloodborne infectious disease ( e.g . HIV , viral hepatitis etc . ) Anemia ( &lt; 11 g/dL hemoglobin ) Jehovah 's Witness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>